Fact check
“During the Biden administration, HHS adopted an alternative test for "accepted medical use" that considers "widespread" clinical experience with a drug and requires "some credible scientific support" for at least one application.”
Reasoning
The provided evidence states that during the Biden administration, HHS adopted an alternative test for "accepted medical use" that considers "widespread" clinical experience and requires "some credible scientific support" for at least one application. This matches the claim word for word.
On confidence: The claim is directly corroborated by a primary source excerpt from Reason.com citing a GAO report and HHS statements.
Important context
The change in criteria was part of a broader discussion on drug scheduling and was referenced in a GAO report discussed in the Reason.com article.
Evidence
Supporting (2)
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
similar to the evidence that the Food and Drug Administration (FDA) demands to approve a drug for prescription use, the DEA's definition essentially equated "accepted medical use" with FDA approval. During the Biden administration, the HHS…
- Tier 1 — Primary sourceFederal drug scheduling relies on vague criteria, GAO report finds
cannabis illustrates that puzzle. When Congress enacted the CSA in 1970, it placed marijuana in Schedule I, and the Drug Enforcement Administration (DEA), which had the authority to reclassify drugs in consultation with the Department of…
Limitations
The evidence is limited to a single media source summarizing the GAO report; the original GAO document was not directly examined. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 1, 2026, 4:49 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Hazy Drug Classification Criteria Invite Dubious Bureaucratic JudgmentsReason · Jacob Sullum